These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36188020)

  • 1. Systemic antibiotic sales and WHO recommendations, India.
    Mehta A; Brhlikova P; McGettigan P; Pollock AM; Roderick P; Farooqui HH
    Bull World Health Organ; 2022 Oct; 100(10):610-619. PubMed ID: 36188020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics.
    Brhlikova P; Mehta A; McGettigan P; Pollock AM; Roderick P; Farooqui HH
    J Pharm Policy Pract; 2023 Nov; 16(1):139. PubMed ID: 37950272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threats to global antimicrobial resistance control: Centrally approved and unapproved antibiotic formulations sold in India.
    McGettigan P; Roderick P; Kadam A; Pollock A
    Br J Clin Pharmacol; 2019 Jan; 85(1):59-70. PubMed ID: 29397576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries.
    Hsia Y; Sharland M; Jackson C; Wong ICK; Magrini N; Bielicki JA
    Lancet Infect Dis; 2019 Jan; 19(1):67-75. PubMed ID: 30522834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs.
    McGettigan P; Roderick P; Mahajan R; Kadam A; Pollock AM
    PLoS Med; 2015 May; 12(5):e1001826; discussion e1001826. PubMed ID: 25965416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
    Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
    Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed dose combinations of anti-tubercular, antimalarial and antiretroviral medicines on the Indian market: critical analysis of ubiquity, sales and regulatory status.
    Ligade VS; Thakar TM; Dengale SJ
    Trop Med Int Health; 2019 Feb; 24(2):238-246. PubMed ID: 30422371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress towards antibiotic use targets in eight high-income countries.
    Simmons B; Ariyoshi K; Ohmagari N; Pulcini C; Huttner B; Gandra S; Satta G; Moja L; Sharland M; Magrini N; Miraldo M; Cooke G
    Bull World Health Organ; 2021 Aug; 99(8):550-561. PubMed ID: 34354310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consumption of systemic antibiotics in India in 2019.
    Koya SF; Ganesh S; Selvaraj S; Wirtz VJ; Galea S; Rockers PC
    Lancet Reg Health Southeast Asia; 2022 Sep; 4():100025. PubMed ID: 37383993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global sales of oral antibiotics formulated for children.
    Li G; Jackson C; Bielicki J; Ellis S; Hsia Y; Sharland M
    Bull World Health Organ; 2020 Jul; 98(7):458-466. PubMed ID: 32742031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries.
    Bortone B; Jackson C; Hsia Y; Bielicki J; Magrini N; Sharland M
    PLoS One; 2021; 16(1):e0241899. PubMed ID: 33471786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable antibiotic use in India: public-private share in volume and cost.
    Fazaludeen Koya S; Ganesh S; Klemperer K; Yadav P; McDonnell A
    Wellcome Open Res; 2024; 9():70. PubMed ID: 39221437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data.
    Klein EY; Milkowska-Shibata M; Tseng KK; Sharland M; Gandra S; Pulcini C; Laxminarayan R
    Lancet Infect Dis; 2021 Jan; 21(1):107-115. PubMed ID: 32717205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adequacy of clinical trial evidence of metformin fixed-dose combinations for the treatment of type 2 diabetes mellitus in India.
    Evans V; Roderick P; Pollock AM
    BMJ Glob Health; 2018; 3(2):e000263. PubMed ID: 29527355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections.
    Moja L; Zanichelli V; Mertz D; Gandra S; Cappello B; Cooke GS; Chuki P; Harbarth S; Pulcini C; Mendelson M; Tacconelli E; Ombajo LA; Chitatanga R; Zeng M; Imi M; Elias C; Ashorn P; Marata A; Paulin S; Muller A; Aidara-Kane A; Wi TE; Were WM; Tayler E; Figueras A; Da Silva CP; Van Weezenbeek C; Magrini N; Sharland M; Huttner B; Loeb M
    Clin Microbiol Infect; 2024 Apr; 30 Suppl 2():S1-S51. PubMed ID: 38342438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not recommended fixed-dose antibiotic combinations in low- and middle-income countries - the example of Tanzania.
    Vliegenthart-Jongbloed K; Jacobs J
    Antimicrob Resist Infect Control; 2023 Apr; 12(1):37. PubMed ID: 37076936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability of access, watch, and reserve (AWaRe) group of antibiotics in community pharmacies located close to a tertiary care hospital in Lalitpur, Nepal.
    Jha N; Thapa B; Pathak SB; Kafle S; Mudvari A; Shankar PR
    PLoS One; 2023; 18(11):e0294644. PubMed ID: 37983218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of rationality of available fixed dose combinations of antibiotics in India.
    Anand P; Kaur N; Verma V; Shafiq N; Malhotra S
    Expert Rev Anti Infect Ther; 2022 May; 20(5):797-808. PubMed ID: 34865581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Antibiotic Use in Kazakhstan for the Period 2017-2019 Based on WHO Access, Watch and Reserve Classification (AWaRe 2019).
    Zhussupova G; Utepova D; Orazova G; Zhaldybayeva S; Skvirskaya G; Tossekbayev K
    Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33430122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
    Sulis G; Batomen B; Kotwani A; Pai M; Gandra S
    PLoS Med; 2021 Jul; 18(7):e1003682. PubMed ID: 34197449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.